To confirm our hypothesis, we established a glucagon overexpressed tumor cell line, OE‐GCG‐CT26, to test whether endogenous glucagon would show the same antitumor effect as 5‐FU (Figure S2B, Supporting Information). This evidence concerns the gene GCG and neoplasm.